NCT00465933View on ClinicalTrials.gov

Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 1999

Primary Completion Date

August 31, 2007

Study Completion Date

November 30, 2007

Conditions
Acute Promyelocytic Leukemia
Interventions
DRUG

AIDA

Trial Locations (2)

Unknown

Hospital La Fe de Valencia, Valencia

Basurtuko Ospitalea, Basurto

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT00465933 - Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) | Biotech Hunter | Biotech Hunter